This test is designed to detect carriers of cystic fibrosis. Cystic fibrosis (CF) is an autosomal recessive disorder of variable severity that affects the pulmonary system, digestive system, and other organ systems. Clinical features of CF include progressive lung disease, pancreatic insufficiency, male infertility, and elevated sweat chloride levels.

This test is designed to detect carriers of cystic fibrosis. Cystic fibrosis (CF) is an autosomal recessive disorder of variable severity that affects the pulmonary system, digestive system, and other organ systems. Clinical features of CF include progressive lung disease, pancreatic insufficiency, male infertility, and elevated sweat chloride levels. Severely affected individuals may require lung transplantation and have shortened life expectancies, primarily due to respiratory failure. Other individuals have milder symptoms, including some males in whom the only finding is infertility due to congenital absence of the vas deferens (CAVD). Cystic fibrosis (MIM 219700) and CAVD (MIM 277180) are caused by pathogenic variants in the CFTR gene (NM_000492). Individuals with a heterozygous pathogenic variant in CFTR are carriers for cystic fibrosis/CAVD and are at risk of having a child with the disorder. If both reproductive partners are cystic fibrosis carriers, the risk for cystic fibrosis in their children is 25%. Cystic fibrosis has a high incidence in non-Hispanic white populations (approximately 1 in 2500 individuals), and a lower prevalence in other ethnic groups. Approximately 70% of CF carriers in non-Hispanic white populations carry the p.Phe508del (deltaF508) pathogenic variant. The American College of Obstetrics and Gynecology (ACOG) recommends offering cystic fibrosis carrier screening to all women who are pregnant or considering pregnancy. This test is intended for pre/post-conception carrier screening and is not intended for diagnostic testing.

Gene(s)

CFTR

MIM

219700 277180

Methodology

Billing

CPT Code(s)
81220 x 1

Ordering

Test Code
6002

Additional Test Codes
Please call for pricing

Turnaround Time
Typically within 2 weeks from receipt of a sample in the laboratory.

Specimens
Whole blood: purple-top (EDTA) tube, minimum of 3 ml
Genomic DNA: minimum of 3 µg (at a concentration of at least 30 ng/µl)

Shipping
Ship all specimen types at room temperature by overnight courier. Do not freeze.

The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. HNL Lab Medicine strongly recommends confirmation of CPT codes with third-party payors and/or the AMA. We assume no responsibility for billing errors due to reliance upon CPT codes provided by HNL Lab Medicine.

News

October 28, 2022

Non-Hodgkin Lymphoma FISH Panel Now Available

B-cell lymphoma is a large group of heterogenous disorders and comprises a majority of non-Hodgkin lymphomas.
Read More
October 20, 2022

Genetic testing for Familial Transthyretin Amyloidosis (TTR) NOW AVAILABLE In-House

Hereditary amyloidosis is a life-threatening disorder that can lead to peripheral neuropathy and heart failure.
Read More
August 08, 2022

Familial hypercholesterolemia (FH)

Familial hypercholesterolemia (FH) is a genetic disorder that increases the likelihood of having coronary heart disease at a younger age. Learn about how to determine if you have hypercholesterolemia and what actions you can take to create better outcomes!

Read More
April 11, 2022

Genome Sequencing: A Vital Tool Used in Identifying and Tracking New COVID-19 Variants

Genome sequencing is reading or decoding the complete genetic information i.e. “Genome” of an organism that is encrypted in the form of a very long string called DNA made up of 4 letters, A, T, G, and C. The genome of an organism essentially determines their physical characteristics and ...
Read More
March 03, 2022

The Effect of Genetics on Individual Heart Health: Early Identification of FH Variations to Optimize Treatment

Test must be ordered by a Physician.

Familial hypercholesterolemia (FH) is a genetic disorder that is characterized by abnormally high blood levels of low-density lipoprotein (LDL) cholesterol, sometimes referred to as "bad cholesterol". This condition affects an estimated 1 in 250 people, and increases the likelihood of developing cardiovascular disease. In fact, FH is estimated to be the cause of 2-3% of heart attacks in individuals younger than age 60.

Read More